QLB After Nephrectomy
CompletedNot applicableNCT03529201
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Oxycodone consumption and postoperative pain intensity in patients undergoing nephrectomy procedures. Of all study participants, 50% will obtain quadratus lumborum block (QLB).
Study details
- Official title
- Effectiveness of Quadratus Lumborum Block After Nephrectomy
- Interventions
- Procedure: QLB
- Device: PCA
- Procedure: GA
- Drug: Oxycodone
- Drug: Sevoflurane
- Drug: Fentanyl
- Drug: Rocuronium
- Sponsor
- Medical University of Lublin
- Collaborators
- Department of Anesthesiology and Intensive Care, F. Chopin Hospital in Rzeszów; Department of Anesthesiology and Intensive Care, J. Śniadecki Hospital in Białystok
- Start date
- 2018-05-07
- Primary completion
- 2019-02-28
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Poland
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * obtained consent * nephrectomy procedure Exclusion Criteria: * coagulopathy allergy to local anesthetics depression, antidepressant drugs treatment epilepsy usage of painkiller before surgery addiction to alcohol or recreational drugs
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03529201